Suborning science for profit: Monsanto, glyphosate, and private science research misconduct
Leland Glenna and
Research Policy, 2021, vol. 50, issue 7
Using documents from a lawsuit filed against the agricultural chemical and biotechnology firm Monsanto (now Bayer), we document a private firm's efforts to distort the scientific peer-review process through ghostwriting, to orchestrate campaigns to retract journal articles, and to influence editorial decisions. The firm's apparent goal was to manipulate the regulatory process so that it could continue selling a product that the firm's own research indicated might be dangerous. The long-term impact has been to threaten the integrity of scientific peer review and public trust in science. The findings have implications for public-private research collaborations, the validity of private-science research, scientific journal policies on conflict-of-interest disclosures, and policies governing the role of private science in regulatory oversight.
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (1) Track citations by RSS feed
Downloads: (external link)
Full text for ScienceDirect subscribers only
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
Persistent link: https://EconPapers.repec.org/RePEc:eee:respol:v:50:y:2021:i:7:s0048733321000925
Access Statistics for this article
Research Policy is currently edited by M. Bell, B. Martin, W.E. Steinmueller, A. Arora, M. Callon, M. Kenney, S. Kuhlmann, Keun Lee and F. Murray
More articles in Research Policy from Elsevier
Bibliographic data for series maintained by Catherine Liu ().